The Latest News

The USCACA Ph1 delegation visited China

November, 2009, the USCACA Ph1 delegation paid their first visit to China. Delegates included representatives of 3 top Ph1 oncology drug research centers in the US, Dr. George Wilding, Director of Carbone Cancer Center at the University of Wisconsin (UWCCC), Dr. Anthony Tolcher, Chief Medical Officer of South Texas Accelerated Research Therapy (START), and Dr. Igor Puzanov, Deputy Director of Ph1 center at Vanderbilt University. Gina Mangold, Chief Operation Officer of START and Dona Alberti, Associate Director of UWCCC joined the delegation.

USCACA executives received Special Contribution Award by China SFDA

(Beijing) On December 6th 2009, USCACA executives Drs. Li Yan and Xiaoxiang Chen, were awarded Special Contribution Award¡¡À by the State Food and Drug Administration (SFDA). The award recognizes their efforts and contributions to the improvement on standardization of Chinese drug review process and revision of the guiding principles.

Asia International Breast Cancer Summit


The Global Breast Cancer Conferenece

The Global Breast Cancer Conferenece is the 7th Breast Biennial Meeting of the Asian Breast Cancer Society held in Seoul, Korea Oct 8-10, 2009. 1300 delegates from 30 countries attended the meeting together with prominent breast cancer researchers and clinicians from USA, Europe and Asia. Wide range of topics were presented at the meeting, including prevention, research and treatment of breast cancer. In addition, psycho-social issues of breast cancer were discussed.

News reporting the launch of USCACA

Chinese Anti-Cancer Association (CACA) reported the launch of USCACA